Molecular subtypes of a bladder cancer: evolution of classifications and clinical significance

Molecular subtypes of a bladder cancer: evolution of classifications and clinical significance

Molecular subtypes of a bladder cancer: evolution of classifications and clinical significance

Bibliographic Details
Main Authors:	O. N. Sulaieva, A. A. Seleznov, D. A. Shapochka, A. E. Stakhovskiy, R. N. Ponomarchuk, P. N. Botsun
Format:	Article
Language:	Russian
Published:	Liga-Inform ltd. 2020-05-01
Series:	Клінічна хірургія
Online Access:	https://hirurgiya.com.ua/index.php/journal/article/view/793

Similar Items

The bladder cancer: the risk factors and prognostic markers
by: O. N. Sulayeva, et al.
Published: (2019-12-01)

Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype
by: Ana Blanca, et al.
Published: (2023-04-01)

Molecular genetic subtypes of bladder cancer
by: S. V. Kotov, et al.
Published: (2023-10-01)

Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial
by: Jon Griffin, et al.
Published: (2024-03-01)

Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
by: Martina Minoli, et al.
Published: (2020-08-01)

Molecular genetic classification of colorectal cancer subtypes: current state of the problem
by: O. I. Kit, et al.
Published: (2021-06-01)

Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation
by: Francesca Sanguedolce, et al.
Published: (2022-07-01)

Mouse models of muscle-invasive bladder cancer: Key considerations for clinical translation based on molecular subtypes
by: Ruan, J, et al.
Published: (2018)

Rare histological subtypes of bladder cancer in clinical practice: a case series
by: Anna A. Paychadze, et al.
Published: (2023-08-01)

Identification of endothelial-related molecular subtypes for bladder cancer patients
by: Deng-xiong Li, et al.
Published: (2023-03-01)

Genetic alterations in the molecular subtypes of bladder cancer: Illustration in the Cancer Genome Atlas dataset
by: Choi, W, et al.
Published: (2017)

A novel classification of lung cancer into molecular subtypes.
by: Lisandra West, et al.
Published: (2012-01-01)

High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes
by: Sébastien Rinaldetti, et al.
Published: (2022-09-01)

Molecular Subtyping in Muscle-Invasive Bladder Cancer on Predicting Survival and Response of Treatment
by: Tanan Bejrananda, et al.
Published: (2022-12-01)

Clinicopathological Features and Survival Analysis in Molecular Subtypes of Muscle-Invasive Bladder Cancer
by: Francesca Sanguedolce, et al.
Published: (2023-04-01)

Causes, consequences and clinical significance of aneuploidy across melanoma subtypes
by: Eva R. Shteinman, et al.
Published: (2022-10-01)

Significance of tumor-associated macrophages in bladder cancer development
by: V. N. Pavlov, et al.
Published: (2022-10-01)

Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation
by: Ying Dong, et al.
Published: (2023-05-01)

Tumour tissue‐derived small extracellular vesicles reflect molecular subtypes of bladder cancer
by: Liang Dong, et al.
Published: (2024-02-01)

Immunohistochemical Study of Bladder Cancer Molecular Subtypes and Their Association with PD-L1 Expression
by: Dimitrios Goutas, et al.
Published: (2022-12-01)

Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancer
by: SungEun Kim, et al.
Published: (2019-04-01)

Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression
by: Francesca Sanguedolce, et al.
Published: (2022-07-01)

An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer
by: Zicheng Xiao, et al.
Published: (2022-09-01)

Clinical Significance of Urine Heparanase in Bladder Cancer Progression
by: Itay Shafat, et al.
Published: (2008-02-01)

Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience
by: Massimiliano Salati, et al.
Published: (2023-01-01)

Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model
by: Kun Zheng, et al.
Published: (2024-04-01)

Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation
by: Hanfei Guo, et al.
Published: (2024-01-01)

Molecular subtypes, tumor microenvironment infiltration characterization and prognosis model based on cuproptosis in bladder cancer
by: Heping Zhang, et al.
Published: (2023-04-01)

Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision
by: Thorsten H. Ecke, et al.
Published: (2022-05-01)

Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
by: Csilla Olah, et al.
Published: (2023-03-01)

The Clinical Significance of Serum Free Light Chains in Bladder Cancer
by: Monika Gudowska-Sawczuk, et al.
Published: (2023-05-01)

Clinical Impact of Molecular Subtyping of Pancreatic Cancer
by: Xu Zhou, et al.
Published: (2021-11-01)

Evaluation of Therapeutic Targets in Histological Subtypes of Bladder Cancer
by: Sophie Wucherpfennig, et al.
Published: (2021-10-01)

Cytofluorometric characteristics of molecular subtypes of breast cancer
by: L. K. Tsoi, et al.
Published: (2014-08-01)

Immunophenotypic features of molecular subtypes of breast cancer
by: S.V. Chulkova, et al.
Published: (2022-10-01)

Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review)
by: Yu. S. Krumin, et al.
Published: (2021-03-01)

Significance of methylation-related genes in diagnosis and subtype classification of renal interstitial fibrosis
by: Hanchao Zhang, et al.
Published: (2023-07-01)

Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival
by: Duaa S. Helal, et al.
Published: (2023-02-01)

Identification of The Immune Subtype Among Muscle-invasive Bladder Cancer Patients by Multiple Datasets
by: Khyber Shinwari, et al.
Published: (2022-01-01)

Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia
by: Olga Krali, et al.
Published: (2023-12-01)